Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease
Abstract Background Alzheimer’s disease (AD) causes substantial medical and societal burden with no therapies ameliorating cognitive deficits. Centralized pathologies involving amyloids, neurofibrillary tangles, and neuroinflammatory pathways are being investigated to identify disease-modifying targ...
Guardado en:
Autores principales: | Avijit Banik, Radhika Amaradhi, Daniel Lee, Michael Sau, Wenyi Wang, Raymond Dingledine, Thota Ganesh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c1524c61ee446028a162ba57509e1d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values
por: Afaf El-Ansary, et al.
Publicado: (2021) -
Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits, Gliosis, and Amyloid-Beta Deposition in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Zackary Bowers, et al.
Publicado: (2021) -
Evaluación del Video Head Impulse Test (V-Hit) en el diagnóstico del neurinoma del acústico
por: Silva C,Mauricio, et al.
Publicado: (2015) -
Construction of the hit-deficient mutant strain of Streptococcus mutans ATCC25175
por: LAI Yangfan, et al.
Publicado: (2021) -
ML218 HCl Is More Efficient Than Capsaicin in Inhibiting Bacterial Antigen-Induced Cal 27 Oral Cancer Cell Proliferation
por: Rajdeep Chakraborty, et al.
Publicado: (2021)